Swift Sync
1 known investors
Swift Sync develops a patented temporary A-V sequential pacing catheter that self-positions in the right-side heart chambers to maintain endocardium contact for synchronous dual-chamber pacing, potentially without fluoroscopic guidance. It is intended for use in operating rooms, cath labs, and critical care settings for procedures such as open heart surgery, TAVR, ablations, and conditions like bradycardia and heart block.
Investors · 1
Frequently asked questions
- What does Swift Sync do?
- Swift Sync develops a patented temporary A-V sequential pacing catheter that self-positions in the right-side heart chambers to maintain endocardium contact for synchronous dual-chamber pacing, potentially without fluoroscopic guidance. It is intended for use in operating rooms, cath labs, and critical care settings for procedures such as open heart surgery, TAVR, ablations, and conditions like bradycardia and heart block.
- Who are Swift Sync's investors?
- Swift Sync's investors include Ocean Azul Partners.